J Jan B van Lanschot
Overview
Explore the profile of J Jan B van Lanschot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
4367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Eyck B, van der Wilk B, Noordman B, Wijnhoven B, Lagarde S, Hartgrink H, et al.
Trials
. 2021 May;
22(1):345.
PMID: 34001287
Background: The Surgery As Needed for Oesophageal cancer (SANO) trial compares active surveillance with standard oesophagectomy for patients with a clinically complete response (cCR) to neoadjuvant chemoradiotherapy. The last patient...
22.
Eyck B, van Lanschot J, Hulshof M, van der Wilk B, Shapiro J, van Hagen P, et al.
J Clin Oncol
. 2021 Apr;
39(18):1995-2004.
PMID: 33891478
Purpose: Preoperative chemoradiotherapy according to the chemoradiotherapy for esophageal cancer followed by surgery study (CROSS) has become a standard of care for patients with locally advanced resectable esophageal or junctional...
23.
van der Bogt R, van der Wilk B, Nikkessen S, Krishnadath K, Schoon E, Oostenbrug L, et al.
Endoscopy
. 2021 Mar;
53(11):1098-1104.
PMID: 33652496
Background: Endoscopic evaluation of the esophageal mucosa may play a role in an active surveillance strategy after neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer. This study investigated the yield of endoscopic...
24.
Valkema M, van der Wilk B, Eyck B, Wijnhoven B, Spaander M, Doukas M, et al.
J Nucl Med
. 2020 Sep;
62(4):486-492.
PMID: 32887759
Active surveillance for patients with esophageal cancer and a clinically complete response (cCR) after neoadjuvant chemoradiotherapy (nCRT) is being studied. Active surveillance requires accurate clinical response evaluations. F-FDG PET/CT might...
25.
van der Wilk B, van Lanschot J
Ann Surg
. 2020 Mar;
274(6):e697-e698.
PMID: 32209908
No abstract available.
26.
Zhang X, Eyck B, Yang Y, Liu J, Chao Y, Hou M, et al.
BMC Cancer
. 2020 Mar;
20(1):194.
PMID: 32143580
Background: After neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, high pathologically complete response (pCR) rates are being achieved especially in patients with squamous cell carcinoma (SCC). An active surveillance strategy has...
27.
Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reports
van der Wilk B, Noordman B, Atmodimedjo P, Dinjens W, Laheij R, Wagner A, et al.
Eur J Med Genet
. 2020 Jan;
63(3):103840.
PMID: 31923587
Familial atypical multiple mole melanoma (FAMMM) syndrome is a hereditary syndrome characterized by multiple dysplastic nevi and melanoma. Patients with FAMMM may have a heterozygous, inactivating, pathogenic germline variant in...
28.
van der Bogt R, van der Wilk B, Poley J, Krishnadath K, Schoon E, Oostenbrug L, et al.
Endoscopy
. 2019 Dec;
52(3):186-192.
PMID: 31816658
Background: Endoscopic ultrasound (EUS) and fine-needle aspiration (FNA) are potential tools for the detection of residual disease after neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer. This study investigated yield of EUS...
29.
Brinkmann S, Noordman B, Holscher A, Biermann K, van Klaveren D, Bollschweiler E, et al.
Ann Surg Oncol
. 2019 Nov;
27(4):1250-1258.
PMID: 31691114
Background: This study was conducted to validate a pretreatment (i.e. prior to neoadjuvant chemoradiotherapy) pathological staging system in the resection specimen after neoadjuvant chemoradiotherapy for esophageal cancer. The study investigated...
30.
van der Wilk B, Noordman B, Neijenhuis L, Nieboer D, Nieuwenhuijzen G, Sosef M, et al.
Ann Surg
. 2019 Oct;
274(6):1009-1016.
PMID: 31592898
Objective: This study compared outcomes of patients with esophageal cancer and clinically complete response (cCR) after neoadjuvant chemoradiotherapy (nCRT) undergoing active surveillance or immediate surgery. Background: Since nearly one-third of...